NCT04681105 2026-01-28Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCity of Hope Medical CenterPhase 1 Completed13 enrolled
NCT00185692 2019-12-04Allogeneic Transplantation From Related Haploidentical DonorsStanford UniversityPhase 2 Completed16 enrolled 8 charts